Kraft Heinz (NASDAQ: KHC) is exploring a potential spinoff of a significant portion of its grocery business, including iconic Kraft-branded products, into a standalone entity that could be valued at up to $20 billion, according to a source familiar with the matter. The structure of the deal is still under review, and there’s no certainty the company will proceed.
This move comes amid growing pressure on consumer packaged goods (CPG) companies to adapt to shifting consumer preferences and inflation-driven spending cutbacks. Kraft Heinz, currently valued at $31.3 billion, has faced declining demand for processed products like Lunchables as shoppers opt for fresher alternatives. The company lowered its annual outlook after a weak earnings report in April and recently scrapped the U.S. launch of new products containing artificial food dyes, following calls by Health Secretary Robert F. Kennedy Jr. for a nationwide ban on synthetic food coloring.
The potential separation would mirror Kellogg’s 2023 strategy, where it spun off its underperforming cereal unit. Analysts suggest more CPG firms may turn to M&A or corporate restructuring to sharpen their category focus and improve revenue growth.
Shares of Kraft Heinz rose 2.5% following news of the potential deal, which was first reported by The Wall Street Journal. The spinoff would leave Kraft Heinz with high-performing products like Heinz ketchup and Grey Poupon mustard.
Kraft Heinz was formed in 2015 through the merger of Kraft Foods and H.J. Heinz, backed by Berkshire Hathaway and 3G Capital. Despite early promise, the investment has struggled amid changing food trends and economic headwinds. The company continues to evaluate strategic options to enhance shareholder value.


Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 



